Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Small interfering RNA-mediated knockdown of notch ligands in primary CD4+ T cells and dendritic cells enhances cytokine production.

Stallwood Y, Briend E, Ray KM, Ward GA, Smith BJ, Nye E, Champion BR, McKenzie GJ.

J Immunol. 2006 Jul 15;177(2):885-95.

PMID:
16818743
[PubMed - indexed for MEDLINE]
Free Article
2.

Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals.

McKenzie G, Ward G, Stallwood Y, Briend E, Papadia S, Lennard A, Turner M, Champion B, Hardingham GE.

BMC Cell Biol. 2006 Feb 28;7:10.

PMID:
16507111
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Notch: a unique therapeutic target for immunomodulation.

McKenzie GJ, Khan M, Briend E, Stallwood Y, Champion BR.

Expert Opin Ther Targets. 2005 Apr;9(2):395-410. Review.

PMID:
15934923
[PubMed - indexed for MEDLINE]
4.

RNA interference.

Stallwood Y.

Pharmacogenomics. 2005 Jan;6(1):13-6. Review. No abstract available.

PMID:
15723601
[PubMed - indexed for MEDLINE]
5.

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW.

Gene Ther. 2001 Mar;8(5):341-8.

PMID:
11313809
[PubMed - indexed for MEDLINE]
Free Article
6.

Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients.

Stallwood Y, Fisher KD, Gallimore PH, Mautner V.

Gene Ther. 2000 Apr;7(8):637-43.

PMID:
10800086
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk